Pharmacophore and 3D-QSAR Studies on 1-Sulfonyl-4-acylpiperazines as Selective Cannabinoid-1 Receptor (CB1R) Inverse Agonists

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|8|7|659-670

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.8, Iss.7, 2011-08, pp. : 659-670

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cannabinoid CB1 and CB2 Receptor Ligand Specificity and the Development of CB2-Selective Agonists

By  

Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. : 1428-1443

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophore Modeling, Atom Based 3D-QSAR and Docking Studies of Protein Tyrosine Phosphatase 1B Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 4, 2013-05 ,pp. : 303-319

Bentham Science Publishers

Access to resources Recommend Favorite

Relative efficacies of cannabinoid CB 1 receptor agonists in the mouse brain

By Burkey T.H.   Quock R.M.   Consroe P.   Ehlert F.J.   Hosohata Y.   Roeske W.R.   Yamamura H.I.  

European Journal of Pharmacology, Vol. 336, Iss. 2, 1997-10 ,pp. : 295-298

Elsevier

Access to resources Recommend Favorite

Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists

By Hill Matthew   Froese Larissa   Morrish Anna   Sun Jane   Floresco Stan  

Psychopharmacology, Vol. 187, Iss. 2, 2006-08 ,pp. : 245-259

Springer Publishing Company

Access to resources Recommend Favorite

Cannabinoid 1 (CB1) Receptor - Pharmacology, Role in Pain and Recent Developments in Emerging CB1 Agonists

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 5, 2011-08 ,pp. : 536-544

Bentham Science Publishers

Access to resources Recommend Favorite